46 Results for

From personalized medicine solutions and automated provider workflows to integrated ecosystems, global experts from BCG and BCG X share their insights on digital health trends.

Extreme weather events such as cyclones and floods will drive increases in the incidence of sickness and death from malaria in Africa, according to a new study.

Health disparities remain wide both across and within countries. Biopharma companies that embed health equity into their strategy can address the problem and position themselves for growth.

By leveraging innovative business models and partnerships, biopharma companies could reach patients in low- and middle-income countries at no extra cost.

Experts across BCG and BCG X foresee an exciting year of technology advances in areas such as at-home care, women’s health, and mental well-being.

BCG conducted a study of more than 70 organizations—including philanthropies, multilateral development banks, government agencies, nongovernmental organizations, private sector actors, and others—to understand how key stakeholders are approaching the climate-health challenge.

Key takeaways from the BCG Henderson Institute’s 2023 Meeting of Minds, which dissected the challenges of demographic aging from a multi-disciplinary perspective and examined emerging solutions for individuals, societies, and businesses.

Done right, ESG can drive positive social impact that reinforces a business’s competitive advantage and contributes to a better world.

The biopharma industry faces demands for more action to address health inequities. We provide a guide and tools to help companies integrate equity across the product lifecycle.

COVID-19 offered valuable lessons in combating epidemic-level disease. Four measures can help institutionalize what we’ve learned.